tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
United Therapeutics price target raised to $587 from $569 at RBC Capital
PremiumThe FlyUnited Therapeutics price target raised to $587 from $569 at RBC Capital
3M ago
United Therapeutics price target raised to $525 from $500 at H.C. Wainwright
Premium
The Fly
United Therapeutics price target raised to $525 from $500 at H.C. Wainwright
3M ago
United Therapeutics price target raised to $447 from $435 at Morgan Stanley
Premium
The Fly
United Therapeutics price target raised to $447 from $435 at Morgan Stanley
3M ago
United Therapeutics price target raised to $575 from $564 at Jefferies
PremiumThe FlyUnited Therapeutics price target raised to $575 from $564 at Jefferies
3M ago
United Therapeutics: Strong Growth Potential Amid Short-Term Volatility Supports Buy Rating
Premium
Ratings
United Therapeutics: Strong Growth Potential Amid Short-Term Volatility Supports Buy Rating
3M ago
Morning Movers: Nvidia jumps after GTC, Trump comments
Premium
The Fly
Morning Movers: Nvidia jumps after GTC, Trump comments
3M ago
United Therapeutics’ AI-Driven Study: A Potential Game-Changer for Pulmonary Hypertension Diagnosis
PremiumCompany AnnouncementsUnited Therapeutics’ AI-Driven Study: A Potential Game-Changer for Pulmonary Hypertension Diagnosis
3M ago
United Therapeutics’ DeciPHer-ILD Study: A Closer Look at PH-ILD Patient Registry
Premium
Company Announcements
United Therapeutics’ DeciPHer-ILD Study: A Closer Look at PH-ILD Patient Registry
3M ago
United Therapeutics’ Xenokidney Study: A New Hope for ESRD Patients
Premium
Company Announcements
United Therapeutics’ Xenokidney Study: A New Hope for ESRD Patients
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100